methylprednisolone and nintedanib

methylprednisolone has been researched along with nintedanib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D1
Ismail, I; Nigam, S; Parnham, A; Srinivasa, V1
Chen, X; Hu, J; Li, Y; Luo, C; Zuo, X1

Other Studies

3 other study(ies) available for methylprednisolone and nintedanib

ArticleYear
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
    Investigacion clinica, 2014, Volume: 55, Issue:1

    Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections

2014
Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.
    Journal of medical case reports, 2017, Aug-06, Volume: 11, Issue:1

    Topics: Anti-Glomerular Basement Membrane Disease; Antineoplastic Agents; Cyclophosphamide; Female; Glomerulonephritis; Hematuria; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Methylprednisolone; Middle Aged; Plasma Exchange; Prednisone; Remission Induction; Treatment Outcome

2017
Pulmonary fibrosis and cytokine release syndrome after hyperactivation with sintilimab.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Colonic Neoplasms; Cytokine Release Syndrome; Glucocorticoids; Humans; Immunotherapy; Indoles; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis

2020